Variant report
Variant | esv3420344 |
---|---|
Chromosome Location | chr21:16263081-16265129 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:16264262..16266414-chr21:16269227..16271133,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572751033 | chr21:16263154-16263155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73895207 | chr21:16263170-16263171 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs553679425 | chr21:16263171-16263172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568254821 | chr21:16263191-16263192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs193233122 | chr21:16263207-16263208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111754513 | chr21:16263225-16263226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564379883 | chr21:16263308-16263309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537396051 | chr21:16263344-16263345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150098746 | chr21:16263384-16263385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370295570 | chr21:16263411-16263412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2822973 | chr21:16263419-16263420 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs2822974 | chr21:16263440-16263441 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs114355335 | chr21:16263460-16263461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550855605 | chr21:16263479-16263480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548291141 | chr21:16263484-16263485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370963406 | chr21:16263531-16263532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548542313 | chr21:16263541-16263542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183694566 | chr21:16263553-16263554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148760343 | chr21:16263614-16263615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34437663 | chr21:16263615-16263616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112880025 | chr21:16263630-16263631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200755552 | chr21:16263719-16263720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201330128 | chr21:16263758-16263759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565382061 | chr21:16263794-16263795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537252908 | chr21:16263817-16263818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561270585 | chr21:16263848-16263849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188017498 | chr21:16263895-16263896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559278950 | chr21:16263960-16263961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571207250 | chr21:16263992-16263993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200179426 | chr21:16264001-16264002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567597933 | chr21:16264110-16264111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566847047 | chr21:16264141-16264142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570948004 | chr21:16264147-16264148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs13049758 | chr21:16264167-16264168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13046960 | chr21:16264174-16264175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201503434 | chr21:16264176-16264177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13046963 | chr21:16264179-16264180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540173047 | chr21:16264218-16264219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs55931363 | chr21:16264229-16264230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139114854 | chr21:16264267-16264268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574820905 | chr21:16264278-16264279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146870304 | chr21:16264279-16264280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs58484696 | chr21:16264285-16264286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189839536 | chr21:16264300-16264301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs553371671 | chr21:16264334-16264335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575030560 | chr21:16264338-16264339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs28830341 | chr21:16264364-16264365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9977201 | chr21:16264365-16264366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200831686 | chr21:16264376-16264377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181887089 | chr21:16264400-16264401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Alzheimer''s disease | 18923514 | CNVD |
Alzheimer''s disease | 20877625 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Alzheimer''s disease | 21956041 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Epilepsy | 20502679 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:16249200-16264600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr21:16260000-16264600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr21:16261200-16263400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr21:16261400-16267000 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr21:16261800-16265200 | Weak transcription | Dnd41 | blood |
6 | chr21:16262000-16263400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
7 | chr21:16262000-16284200 | Weak transcription | Primary hematopoietic stem cells | blood |
8 | chr21:16264600-16264800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr21:16264600-16265000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr21:16264600-16265000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr21:16264800-16265800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |